Generative AI can be used to combat misinformation. However, it can also exacerbate the problem by producing convincing ...
Actigraphy data show irregular sleep-wake rhythms nearly double the risk for relapse in individuals with remitted major depressive disorder.
Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2025 financial results and provided a corporate update.
Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...
Complete relief pitcher rankings with 2026 projections and player-by-player analysis.
Could a smart watch act as an early-warning system for depression relapse? New research from McMaster University suggests ...
Maternal mortality remains disproportionately high in low-income and middle-income countries, where pyramidal health systems ...
The search space for protein engineering grows exponentially with complexity. A protein of just 100 amino acids has 20100 ...
From anesthesia stipends to implant sticker shock, ASC leaders say the math between what it costs to run cases and what payers reimburse is breaking down. Twenty-two ASC leaders joined Becker’s to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results